Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intervertebral Disc Regeneration Mediated by Autologous Mesenchymal Stem/Stromal Cells Intradiscal Injection: a Phase IIB Randomized Clinical Trial - DREAM Trial

NCT05066334 is registered in ClinicalTrials.gov with Fondazione Policlinico Universitario Campus Bio-Medico as lead sponsor.

NCT NCT05066334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05066334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intervertebral Disc Regeneration Mediated by Autologous Mesenchymal Stem/Stromal Cells Intradiscal Injection: a Phase IIB Randomized Clinical Trial - DREAM Trial
Lead sponsor
Fondazione Policlinico Universitario Campus Bio-Medico
Phase
Phase 2
Overall status
Recruiting
Start date
March 22, 2021
Completion date
October 31, 2025
Enrollment
52 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic low-back pain, intervertebral disc degeneration